# Resting Heart Rate Monitoring for Optimized Treatment and Surveillance of Hyperthyroidism

> **NCT04932135** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 35 (actual)

## Conditions studied

- Hyperthyroidism
- Graves Disease

## Interventions

- **DIAGNOSTIC_TEST:** Continuous heart rate monitoring

## Key facts

- **NCT ID:** NCT04932135
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-08
- **Primary completion:** 2023-03-21
- **Final completion:** 2023-10-30
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2023-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04932135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04932135, "Resting Heart Rate Monitoring for Optimized Treatment and Surveillance of Hyperthyroidism". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04932135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*